Skandinaviska Enskilda Banken Ab (Publ) Repligen Corp Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.5 Billion
- Q3 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Repligen Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 150 shares of RGEN stock, worth $25,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 10,793
98.61%
Holding current value
$25,410
Previous $1.36 Million
98.38%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding RGEN
# of Institutions
480Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.28 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.08 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$855 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$275 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$241 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $9.4B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....